Prognostic value of serum Tie-2 and vascular endothelial growth factor levels in cancer patients

Seker, M.; Sancaktar, E.; Acibucu, D.; Filiz, AHMET; Deveci, K.; Bahceci, A.; Kacan, T.; Babacan, N.; Yuce, S.

Prognostic value of serum Tie-2 and vascular endothelial growth factor levels in cancer patients

Seker M. M., Sancaktar E., Acibucu D. O., Filiz A. K., Deveci K., Bahceci A., ...Daha Fazla

EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, cilt.17, sa.21, ss.2929-2932, 2013 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 17 Sayı: 21
Basım Tarihi: 2013
Dergi Adı: EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.2929-2932
Anahtar Kelimeler: Tie-2, Vascular endothelial growth factor, Cancer, Prognosis, ANGIOPOIETIN-2 LEVELS, PLASMA-CONCENTRATIONS, DISEASE PROGRESSION, COLORECTAL-CANCER, RECEPTOR, ANGIOGENESIS, RESISTANCE, PATHWAY, TUMOR
Sivas Cumhuriyet Üniversitesi Adresli: Evet

Özet

BACKGROUND: Angiogenesis is a very essential process in tumor biology. Vascular endothelial growth factor (VEGF), angiopoietin and its receptor (TIE-2) are very important mediators for angiogenesis. In this trial, we aimed to analyze the role of these mediators on chemotherapy response and survival.